Search - tctmd.com

Displaying 1 - 20 of 81

Sort: Relevancy | Date

News Daily News

Early TAVI Valve Deterioration More Likely in Younger Patients, Smaller Annuli

Yael L. Maxwell

September 04, 2025

News Conference News HVS 2025

Solid Durability Seen With Surgical Resilia Tissue Aortic Valve

Yael L. Maxwell

April 21, 2025

News Conference News EuroPCR 2024

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

Shelley Wood

May 16, 2024

Presentation EuroPCR 2024

First report of an IDE pivotal study of a dedicated splitting device during TAVR

Presenter: Danny Dvir

May 15, 2024

News Conference News PCR London Valves 2022

Earlier Interventions and Later Redos? ‘Mature’ TAVI Still Has Growing Pains

Shelley Wood

November 28, 2022

News Conference News CRT 2021

Low Mortality and Stroke Rates With BASILICA Pre-TAVI, Registry Shows

Michael O'Riordan

March 09, 2021

News Conference News TCT 2020

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

Caitlin E. Cox

October 14, 2020

News Conference News EuroPCR 2020

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

Yael L. Maxwell

July 03, 2020

News Daily News

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

Yael L. Maxwell

February 14, 2020

Presentation Live Valves 2019

Failed Aortic Valve Bioprostheses: Valve-in-Valve or Redo-SAVR?

Presenter: Danny Dvir

December 10, 2019

News Daily News

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

Todd Neale

November 20, 2018

News Daily News

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Caitlin E. Cox

July 16, 2018

News Conference News CRT 2018

Ticagrelor: Better Platelet Blockade Post-TAVR?

Michael O'Riordan

March 07, 2018

News Conference News CRT 2018

Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better

Shelley Wood

March 05, 2018

News Daily News

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Michael O'Riordan

January 26, 2018

Presentation TVT 2017

Selecting Patients for ViV and ViR: Can We Predict Success and Complications?

Presenter: Saibal Kar, Danny Dvir

June 15, 2017

Presentation TVT 2017

The Use and Potential Advantages of Alternative TAVR Systems for Treating Aortic Bioprosthesis Failure (Acurate, Lotus, and Portico)

Presenter: Ran Kornowski, Mark J. Russo, Danny Dvir

June 15, 2017

Presentation TVT 2017

Featured Lecture: Transcatheter Valve-in-Valve Implantations: Lessons From Bench to Bedside (VIVID Registry)

Presenter: Ran Kornowski, Mark J. Russo, Danny Dvir

June 15, 2017

Manuscript

Transcatheter Aortic Valve Replacement for Failed Surgical Bioprostheses: Insights from the PARTNER II Valve-in-Valve Registry on Utilizing Baseline Computed-Tomographic Assessment

May 31, 2017

News Conference News EuroPCR 2017

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

Caitlin E. Cox

May 17, 2017

Advertisement

Early TAVI Valve Deterioration More Likely in Younger Patients, Smaller Annuli

Solid Durability Seen With Surgical Resilia Tissue Aortic Valve

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

First report of an IDE pivotal study of a dedicated splitting device during TAVR

Earlier Interventions and Later Redos? ‘Mature’ TAVI Still Has Growing Pains

Low Mortality and Stroke Rates With BASILICA Pre-TAVI, Registry Shows

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

Failed Aortic Valve Bioprostheses: Valve-in-Valve or Redo-SAVR?

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Ticagrelor: Better Platelet Blockade Post-TAVR?

Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Selecting Patients for ViV and ViR: Can We Predict Success and Complications?

The Use and Potential Advantages of Alternative TAVR Systems for Treating Aortic Bioprosthesis Failure (Acurate, Lotus, and Portico)

Featured Lecture: Transcatheter Valve-in-Valve Implantations: Lessons From Bench to Bedside (VIVID Registry)

Transcatheter Aortic Valve Replacement for Failed Surgical Bioprostheses: Insights from the PARTNER II Valve-in-Valve Registry on Utilizing Baseline Computed-Tomographic Assessment

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content